Activate Immunotherapy Report issue

For profit Phase 3
Founded: San Diego CA United States (1997)
Status: Acquired by Viopro (2015)

Organization Overview

First Clinical Trial
2003
NCT01058785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree